Candel Therapeutics, Inc.CADLNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank33
3Y CAGR-62.6%
5Y CAGR-9.3%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-62.6%/yr
Annual compound
5Y CAGR
-9.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -87.9% |
| 2024 | 0.13 | -77.2% |
| 2023 | 0.55 | +90.3% |
| 2022 | 0.29 | +4525.5% |
| 2021 | 0.01 | -74.6% |
| 2020 | 0.02 | +170.1% |
| 2019 | 0.01 | - |